3,4-methylenedioxyamphetamine has been researched along with Cataract in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devamanoharan, PS | 1 |
| Henein, M | 1 |
| Morris, S | 1 |
| Ramachandran, S | 1 |
| Richards, RD | 1 |
| Varma, SD | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Cataract
| Article | Year |
|---|---|
Prevention of selenite cataract by vitamin C.
Topics: 3,4-Methylenedioxyamphetamine; Adenosine Triphosphate; Animals; Aqueous Humor; Ascorbic Acid; Catara | 1991 |